ARCHIVES

Dendritic Cell Vaccine Increases PFS in Phase II Clinical Trial

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

In Brief: James Downing named CEO of St. Jude

June 27, 2014

NCI’s Breast Cancer Screening Guidelines Released In Draft

September 24, 1993

Surgeons Feel Cooperative Groups Discriminate Against Them, Ask For Better Deals From CCIRC

March 11, 1977

“Projects For Special Donors” – ACS Considering Way To Raise Vast New Sums For Cancer Program

March 31, 1978

Katterhagen, Nelson Reelected ACCC Leaders

February 4, 1977

NCI, Advisers Lean To Smaller Increases For R01a, Philosophy Of Spreading Money Among More Grants

January 15, 1982